Short Term Effect of Empagliflozin in Hypertension
Status:
Completed
Trial end date:
2017-09-30
Target enrollment:
Participant gender:
Summary
The investigators assessed the 6-week effect of once daily 25mg SGLT2-i Empagliflozin on left
ventricular diastolic function and blood pressure profile in non diabetic hypertensive
patients